The company will use the fresh proceeds to strengthen its patents and continue developing its main drug candidate, AVA-NP-695, as well as other early-stage drugs.
Latest Stories
Global Indian
Discover inspiring stories of global Indians giving back to their roots through impactful philanthropy, education, and community development, driving meaningful change in India.